It should always be administered under medical supervision to ensure proper dosage, safety, and effectiveness for individual health needs and treatment goals
In clinical research, women treated with PT-141 showed: Statistically significant improvements in sexual desire scores Increased number of satisfying sexual events Higher scores on the Female Sexual Function Index Reduced distress as measured by the Female Sexual Distress Scale These improvements were not limited to physical measures alone
Safety Considerations and Who Should Start Conservatively Female patients with liver disease, severe kidney impairment, or uncontrolled thyroid dysfunction require careful dosing oversight and may need lower starting doses or extended monitoring intervals
Save the published price, renewal details, medication cost details, delivery note, cancellation window, and refund policy before you pay so you can compare offers with a record in hand
PMID 9465822
